We are live on ! Find out more
AVXL icon

Anavex Life Sciences

62 hedge funds and large institutions have $41.5M invested in Anavex Life Sciences in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

2% more funds holding

Funds holding: 6162 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.08% less ownership

Funds ownership: 24.88%23.8% (-1.1%)

24% less capital invested

Capital invested by funds: $54.7M → $41.5M (-$13.2M)

87% less call options, than puts

Call options by funds: $593K | Put options by funds: $4.65M

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
22
Reduced
13
Closed
5
Calls
$593K
Puts
$4.65M
Net Calls
-$4.05M
Net Calls Change
+$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$118K
TSS
27
Two Sigma Securities
New York
$118K +$66.2K +14,895 +110%
AIG
28
American International Group
New York
$102K +$8.16K +1,835 +8%
VF
29
Virtu Financial
New York
$102K +$110K +24,671 New
Barclays
30
Barclays
United Kingdom
$96K +$94.8K +21,328 +1,168%
Millennium Management
31
Millennium Management
New York
$95K -$99K -22,269 -49%
NIC
32
Northwest Investment Counselors
Oregon
$83K
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$79K -$56.4K -12,687 -40%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$79K
NFA
35
Nationwide Fund Advisors
Ohio
$77K
VOYA Investment Management
36
VOYA Investment Management
Georgia
$75K
TRCT
37
Tower Research Capital (TRC)
New York
$74K +$79.4K +17,868 New
CG
38
Cutler Group
California
$72K +$24K +5,397 +44%
AWM
39
AllSquare Wealth Management
New York
$68K +$33.1K +7,440 +84%
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$66K +$22.9K +5,150 +46%
Simplex Trading
41
Simplex Trading
Illinois
$64K +$66.9K +15,053 +2,334%
ARTA
42
A.R.T. Advisors
New York
$63K +$68K +15,289 New
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$61K +$65K +14,616 New
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$48K +$51K +11,475 New
SO
45
STRS Ohio
Ohio
$39K
Legal & General Group
46
Legal & General Group
United Kingdom
$34K +$16.2K +3,652 +80%
UBS Group
47
UBS Group
Switzerland
$31K -$80 -18 -0.2%
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$20K +$3.56K +800 +20%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$18K +$14.1K +3,163 +319%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$11.7K +$1.97K +443 +19%

AVXL Hedge Fund Activity: Q3 2017 in Review

62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2017, worth a combined $41.5M — down 24% from $54.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AVXL positions and 5 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $404K. The largest seller was Park West Asset Management, cutting an estimated $1.91M.

  • 62 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2017, up from 61 in Q2 2017.
  • Funds reported $41.5M of Anavex Life Sciences stock for Q3 2017, down 24% quarter-over-quarter.
  • 7 funds opened new Anavex Life Sciences positions in Q3 2017 and 5 closed out, a net change of +2 holders.
  • The largest Anavex Life Sciences buyer in Q3 2017 was BlackRock, an estimated $404K added.
  • The largest Anavex Life Sciences seller in Q3 2017 was Park West Asset Management, an estimated $1.91M sold.

Based on aggregated 13F filings for Q3 2017.